Pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a synergistic combination of a carotene and at least one phytosterol wherein the ratio of said lycopene to said phytosterol in said pharmaceutical composition is a maximum of about 5:1 and wherein said composition produces a synergistic inhibition of cell growth and anti-inflammatory effects are disclosed.